Total Payments
$34,810
2024 Payments
$103.82
Companies
23
Transactions
70
Medicare Patients
3,217
Medicare Billing
$317,415
Payment Breakdown by Category
Other$31,146 (89.5%)
Food & Beverage$1,525 (4.4%)
Gifts$1,416 (4.1%)
Education$456.62 (1.3%)
Travel$266.27 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $31,146 | 1 | 89.5% |
| Food and Beverage | $1,525 | 58 | 4.4% |
| Gift | $1,416 | 1 | 4.1% |
| Education | $456.62 | 9 | 1.3% |
| Travel and Lodging | $266.27 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $31,201 | 3 | $0 (2021) |
| NxThera, Inc. | $1,416 | 1 | $0 (2017) |
| Boston Scientific Corporation | $669.85 | 8 | $0 (2023) |
| Astellas Pharma US Inc | $460.28 | 18 | $0 (2021) |
| Janssen Biotech, Inc. | $260.72 | 10 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $241.14 | 2 | $0 (2023) |
| Amgen Inc. | $128.62 | 2 | $0 (2022) |
| PFIZER INC. | $83.11 | 4 | $0 (2024) |
| Telix Pharmaceuticals | $44.92 | 2 | $0 (2024) |
| AbbVie, Inc. | $44.74 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.82 | 4 | Telix Pharmaceuticals ($44.92) |
| 2023 | $219.25 | 4 | AstraZeneca Pharmaceuticals LP ($116.16) |
| 2022 | $71.58 | 4 | Ambu Inc. ($31.15) |
| 2021 | $31,418 | 7 | NeoTract Inc. ($31,146) |
| 2020 | $28.61 | 2 | Janssen Biotech, Inc. ($14.75) |
| 2019 | $876.57 | 18 | Boston Scientific Corporation ($567.85) |
| 2018 | $105.91 | 8 | Astellas Pharma US Inc ($39.00) |
| 2017 | $1,987 | 23 | NxThera, Inc. ($1,416) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 05/04/2024 | Telix Pharmaceuticals | — | Food and Beverage | In-kind items and services | $22.46 | General |
| 04/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $39.99 | General |
| Category: ONCOLOGY | ||||||
| 09/01/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $71.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $116.16 | General |
| 05/15/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Oncology | ||||||
| 03/21/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Oncology | ||||||
| 10/04/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $31.15 | General |
| 04/12/2022 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 02/02/2022 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Urology Gynecology | ||||||
| 10/06/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Respiratory | ||||||
| 08/16/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: UROLOGY | ||||||
| 08/09/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 07/12/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: ONCOLOGY | ||||||
| 07/07/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/25/2021 | NeoTract Inc. | UroLift System (Device) | Debt forgiveness | Cash or cash equivalent | $31,146.11 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 03/31/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: ONCOLOGY | ||||||
| 02/04/2020 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 01/21/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Oncology | ||||||
| 12/20/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 12/03/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 10/01/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 677 | 981 | $193,675 | $46,570 |
| 2022 | 10 | 777 | 1,256 | $231,795 | $60,435 |
| 2021 | 18 | 981 | 1,709 | $521,747 | $122,642 |
| 2020 | 13 | 782 | 1,200 | $361,505 | $87,768 |
Total Patients
3,217
Total Services
5,146
Medicare Billing
$317,415
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 199 | $49,750 | $14,659 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 119 | $41,650 | $11,234 | 27.0% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 108 | 194 | $20,370 | $6,834 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $27,500 | $6,643 | 24.2% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 98 | 107 | $13,910 | $5,297 | 38.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 71 | 74 | $37,000 | $824.34 | 2.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 112 | 176 | $2,640 | $600.16 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 57 | $855.00 | $478.80 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 189 | $65,790 | $18,876 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 146 | $36,500 | $10,050 | 27.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 30 | 166 | $21,029 | $8,812 | 41.9% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2022 | 131 | 236 | $24,780 | $8,298 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $22,350 | $6,162 | 27.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 99 | 118 | $15,340 | $6,087 | 39.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 70 | 79 | $39,500 | $940.62 | 2.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 127 | 192 | $2,880 | $649.74 | 22.6% |
| 99424 | Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | Office | 2022 | 15 | 16 | $2,591 | $359.76 | 13.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 61 | 69 | $1,035 | $201.39 | 19.5% |
| 53854 | Destruction of prostate tissue accessed through urethra using radiofrequency generated water vapor heat therapy | Office | 2021 | 16 | 16 | $112,000 | $28,425 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 210 | $73,500 | $21,952 | 29.9% |
| G2064 | Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic co | Office | 2021 | 61 | 295 | $65,472 | $21,417 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 202 | $50,500 | $15,224 | 30.1% |
| 76857 | Ultrasound of pelvis, limited, not pregnancy related | Office | 2021 | 129 | 281 | $29,505 | $10,509 | 35.6% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2021 | 103 | 125 | $16,250 | $6,715 | 41.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $22,500 | $6,314 | 28.1% |
About Dr. Binod Sinha, MD
Dr. Binod Sinha, MD is a Urology healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134293723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Binod Sinha, MD has received a total of $34,810 in payments from pharmaceutical and medical device companies, with $103.82 received in 2024. These payments were reported across 70 transactions from 23 companies. The most common payment nature is "Debt forgiveness" ($31,146).
As a Medicare-enrolled provider, Sinha has provided services to 3,217 Medicare beneficiaries, totaling 5,146 services with total Medicare billing of $317,415. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Orange City, FL
- Active Since 11/17/2006
- Last Updated 06/10/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134293723
Products in Payments
- UroLift System (Device) $31,146
- Rezum (Device) $1,416
- GENERAL BPH (Device) $550.99
- XTANDI (Drug) $183.99
- FASENRA (Biological) $124.98
- Erleada (Drug) $123.20
- Prolia (Biological) $115.38
- ZYTIGA (Drug) $115.36
- WATCHMAN FLX (Device) $71.97
- Myrbetriq (Drug) $65.91
- Urolift - UL400 (Device) $54.53
- Androgel (Drug) $44.74
- ERLEADA (Drug) $30.70
- Xofigo (Drug) $30.16
- GENERAL PAIN MANAGEMENT (Device) $30.03
- VECTRIS (Device) $27.43
- PROVENGE (Drug) $24.28
- DRG IPGs (Device) $23.24
- ILLUCCIX (Drug) $22.46
- PROLARIS (Device) $18.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.